ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $51,000 | +64.5% | 14,819 | +19.5% | 0.00% | – |
| Q4 2020 | $31,000 | -42.6% | 12,401 | -48.5% | 0.00% | – |
| Q2 2020 | $54,000 | +28.6% | 24,087 | +46.2% | 0.00% | – |
| Q1 2020 | $42,000 | -59.2% | 16,481 | -46.3% | 0.00% | -100.0% |
| Q2 2019 | $103,000 | +186.1% | 30,693 | +130.9% | 0.00% | – |
| Q1 2019 | $36,000 | -41.0% | 13,294 | +13.7% | 0.00% | -100.0% |
| Q2 2018 | $61,000 | -26.5% | 11,692 | -23.1% | 0.00% | 0.0% |
| Q1 2018 | $83,000 | -54.1% | 15,211 | -31.5% | 0.00% | -50.0% |
| Q4 2017 | $181,000 | +248.1% | 22,217 | +118.2% | 0.00% | +100.0% |
| Q3 2016 | $52,000 | -49.5% | 10,183 | -55.1% | 0.00% | 0.0% |
| Q1 2016 | $103,000 | -39.4% | 22,700 | -29.7% | 0.00% | 0.0% |
| Q2 2014 | $170,000 | – | 32,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |